XTX Topco Ltd Takes Position in LivaNova PLC (NASDAQ:LIVN)

XTX Topco Ltd acquired a new position in shares of LivaNova PLC (NASDAQ:LIVN) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 10,464 shares of the company’s stock, valued at approximately $550,000.

A number of other hedge funds have also modified their holdings of LIVN. Fifth Third Bancorp boosted its position in LivaNova by 97.1% during the 2nd quarter. Fifth Third Bancorp now owns 674 shares of the company’s stock worth $37,000 after acquiring an additional 332 shares during the last quarter. Canada Pension Plan Investment Board acquired a new position in LivaNova during the second quarter worth $88,000. Central Pacific Bank Trust Division bought a new position in LivaNova in the third quarter valued at $178,000. TradeLink Capital LLC acquired a new stake in LivaNova in the 2nd quarter valued at $208,000. Finally, Captrust Financial Advisors bought a new stake in LivaNova during the 3rd quarter worth about $217,000. 97.64% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on LIVN shares. Needham & Company LLC restated a “buy” rating and issued a $75.00 price objective on shares of LivaNova in a report on Monday, November 25th. Robert W. Baird boosted their price target on LivaNova from $66.00 to $72.00 and gave the stock an “outperform” rating in a research report on Thursday, October 31st. Baird R W raised LivaNova from a “hold” rating to a “strong-buy” rating in a report on Tuesday, September 17th. StockNews.com downgraded shares of LivaNova from a “strong-buy” rating to a “buy” rating in a report on Saturday, November 16th. Finally, Mizuho cut their price target on shares of LivaNova from $80.00 to $70.00 and set an “outperform” rating for the company in a research note on Thursday, October 31st. One investment analyst has rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus price target of $69.17.

LivaNova Trading Down 1.2 %

LIVN stock opened at $51.50 on Friday. LivaNova PLC has a one year low of $43.15 and a one year high of $64.47. The stock has a market cap of $2.80 billion, a price-to-earnings ratio of 122.62 and a beta of 0.98. The company has a fifty day moving average price of $52.02 and a two-hundred day moving average price of $51.60. The company has a debt-to-equity ratio of 0.46, a current ratio of 3.37 and a quick ratio of 2.87.

Insider Buying and Selling

In other LivaNova news, Director Francesco Bianchi sold 1,250 shares of the firm’s stock in a transaction that occurred on Wednesday, December 11th. The shares were sold at an average price of $50.99, for a total transaction of $63,737.50. Following the completion of the sale, the director now directly owns 7,522 shares in the company, valued at $383,546.78. This trade represents a 14.25 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. 0.27% of the stock is currently owned by insiders.

LivaNova Company Profile

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.